New technologies in the myeloma gene mine

Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

Blood cancer journal·2023

Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.

Cell chemical biology·2022

Understanding Drug Sensitivity and Tackling Resistance in Cancer.

Cancer research·2022

Pharmacogenomics education, research and clinical implementation in the state of Minnesota.

Pharmacogenomics·2021

Discovering genetic interactions bridging pathways in genome-wide association studies.

Nature communications·2019

Identification of a de novo FOXP1 mutation and incidental discovery of inherited genetic variants contributing to a case of autism spectrum disorder and epilepsy.

Molecular genetics & genomic medicine·2019

Restoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT.

Blood·2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

Immune cell subsets that predict cytomegalovirus reactivation magnitude after haematopoietic stem cell transplantation.

Blood·2026

Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.

Blood·2026

Endothelial PIEZO1 regulates Weibel-Palade body exocytosis.

Blood·2026

Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

Blood·2026

Trojan mast cells: repurposing allergy for targeted oncolytic delivery.

Trends in pharmacological sciences·2026

Remote photobiomodulation: A systemic approach to neuroprotection.

International review of neurobiology·2026

Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026

Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor.

Antiviral research·2026

A first realization of reinforcement learning-based closed-loop EEG-TMS.

NeuroImage·2026

FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Related Experiment Videos

New technologies in the myeloma gene mine

Related Concept Videos

Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.

Understanding Drug Sensitivity and Tackling Resistance in Cancer.

Pharmacogenomics education, research and clinical implementation in the state of Minnesota.

Discovering genetic interactions bridging pathways in genome-wide association studies.

Identification of a de novo FOXP1 mutation and incidental discovery of inherited genetic variants contributing to a case of autism spectrum disorder and epilepsy.

Restoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT.

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Immune cell subsets that predict cytomegalovirus reactivation magnitude after haematopoietic stem cell transplantation.

Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.

Endothelial PIEZO1 regulates Weibel-Palade body exocytosis.

Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

Trojan mast cells: repurposing allergy for targeted oncolytic delivery.

Remote photobiomodulation: A systemic approach to neuroprotection.

Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.

Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor.

A first realization of reinforcement learning-based closed-loop EEG-TMS.

FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.

Related Experiment Videos

New technologies in the myeloma gene mine

Related Concept Videos

Related Articles